Man Group
PTCT icon

Man Group’s PTC Therapeutics PTCT Stock Holding History

Man Group’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-16,185
Closed -$1.23M – 2536
2025
Q4 		$1.23M Sell
16,185
-248,996
-94% -$18.1M ﹤0.01% 1619
2025
Q3 		$16.3M Sell
265,181
-406,332
-61% -$21.2M 0.03% 581
2025
Q2 		$32.8M Buy
671,513
+410,653
+157% +$19.5M 0.06% 342
2025
Q1 		$13.3M Buy
+260,860
New +$13M 0.03% 608
2024
Q1 		– Sell
-9,700
Closed -$267K – 2245
2023
Q4 		$267K Buy
+9,700
New +$222K ﹤0.01% 1848
2023
Q3 		– Sell
-11,226
Closed -$417K – 567
2023
Q2 		$457K Buy
+11,226
New +$549K ﹤0.01% 1615
2023
Q1 		– Sell
-189,561
Closed -$7.24M – 2211
2022
Q4 		$7.24M Buy
+189,561
New +$7.88M 0.03% 698
2022
Q2 		– Sell
-24,306
Closed -$852K – 1275
2022
Q1 		$907K Buy
+24,306
New +$936K ﹤0.01% 1404
2021
Q2 		– Sell
-38,669
Closed -$1.83M – 2065
2021
Q1 		$1.83M Sell
38,669
-36,263
-48% -$2.15M 0.01% 1137
2020
Q4 		$4.57M Sell
74,932
-19,949
-21% -$1.18M 0.02% 856
2020
Q3 		$4.44M Sell
94,881
-21,903
-19% -$1.08M 0.02% 874
2020
Q2 		$5.93M Buy
116,784
+62,206
+114% +$3.06M 0.03% 589
2020
Q1 		$2.43M Sell
54,578
-8,179
-13% -$412K 0.02% 809
2019
Q4 		$3.01M Sell
62,757
-1,000
-2% -$42.5K 0.01% 1188
2019
Q3 		$2.16M Sell
63,757
-81,844
-56% -$3.56M 0.01% 1221
2019
Q2 		$6.55M Sell
145,601
-29,419
-17% -$1.16M 0.02% 839
2019
Q1 		$6.59M Buy
175,020
+19,963
+13% +$670K 0.03% 768
2018
Q4 		$5.32M Sell
155,057
-12,247
-7% -$440K 0.02% 740
2018
Q3 		$7.86M Buy
167,304
+19,782
+13% +$819K 0.03% 742
2018
Q2 		$4.98M Buy
+147,522
New +$4.6M 0.02% 946

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Man Group's PTCT Position: Q1 2026 in Review

Man Group sold out of PTC Therapeutics (PTCT) in Q1 2026, closing a stake of 16,185 shares — an estimated $1.23M sold.

Man Group first reported a position in PTCT in Q2 2018 and held it in 20 quarters. The position peaked at $32.8M in Q2 2025. 352 funds tracked by Wall St. Rank hold PTCT as of Q1 2026.

  • Man Group reported no remaining PTC Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Man Group sold 16,185 PTC Therapeutics shares in Q1 2026, an estimated $1.23M.
  • Man Group first reported a position in PTC Therapeutics in Q2 2018 and held it in 20 quarters.
  • Man Group's PTC Therapeutics position peaked at $32.8M in Q2 2025.
  • 352 funds tracked by Wall St. Rank held PTC Therapeutics as of Q1 2026.

Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.